Diabetes Drugs and NPCDiabetes Drugs and NPCRiskcarcinoma risk.SGLT2I may reduce nasopharyngealOncologyNew Insights on Nasopharyngeal Carcinoma and Diabetes MedicationsStudy suggests SGLT2I may lower NPC risk in diabetes patients.2025-09-11T12:55:30+00:00 ― 5 min read